The New York Times editorial board laid out five questions the Senate Finance Committee should ask the seven pharmaceutical companies testifying at a hearing Feb. 26. 1. How are list prices determined ...

While cancer treatment is progressing at a fast rate the world over with new targeted drugs being launched, immunotherapy and radiation, therapy resistance continues to remain an obstacle in the road ...

Exclusive interviews revealed that digital transformation, data integrity protocols, and a regionalized supply chain are crucial strategies for optimizing drug development and manufacturing efficiency ...